81 related articles for article (PubMed ID: 27318143)
21. The interaction of APOE genotype by age in amnestic mild cognitive impairment: a voxel-based morphometric study.
Chen J; Shu H; Wang Z; Liu D; Shi Y; Zhang X; Zhang Z
J Alzheimers Dis; 2015; 43(2):657-68. PubMed ID: 25114090
[TBL] [Abstract][Full Text] [Related]
22. Influence and interactions of cathepsin D, HLA-DRB1 and APOE on cognitive abilities in an older non-demented population.
Payton A; van den Boogerd E; Davidson Y; Gibbons L; Ollier W; Rabbitt P; Worthington J; Horan M; Pendleton N
Genes Brain Behav; 2006; 5 Suppl 1():23-31. PubMed ID: 16417614
[TBL] [Abstract][Full Text] [Related]
23. ApoE alleles and tau markers in patients with different levels of cognitive impairment.
Lavados M; Farías G; Rothhammer F; Guillon M; Mujica MC; Maccioni C; Maccioni RB
Arch Med Res; 2005; 36(5):474-9. PubMed ID: 16099324
[TBL] [Abstract][Full Text] [Related]
24. APOE genotype modulates the effect of serum calcium levels on cognitive function in old age.
van Vliet P; Oleksik AM; Mooijaart SP; de Craen AJ; Westendorp RG
Neurology; 2009 Mar; 72(9):821-8. PubMed ID: 19255409
[TBL] [Abstract][Full Text] [Related]
25. Plasma levels of apolipoprotein E and cognitive function in old age.
Mooijaart SP; van Vliet P; van Heemst D; Rensen PC; Berbée JF; Jolles J; de Craen AJ; Westendorp RG
Ann N Y Acad Sci; 2007 Apr; 1100():148-61. PubMed ID: 17460173
[TBL] [Abstract][Full Text] [Related]
26. Apolipoprotein E genotype and the diagnostic accuracy of cerebrospinal fluid biomarkers for Alzheimer disease.
Lautner R; Palmqvist S; Mattsson N; Andreasson U; Wallin A; Pålsson E; Jakobsson J; Herukka SK; Owenius R; Olsson B; Hampel H; Rujescu D; Ewers M; Landén M; Minthon L; Blennow K; Zetterberg H; Hansson O;
JAMA Psychiatry; 2014 Oct; 71(10):1183-91. PubMed ID: 25162367
[TBL] [Abstract][Full Text] [Related]
27. APOE moderates the association between lifestyle activities and cognitive performance: evidence of genetic plasticity in aging.
Runge SK; Small BJ; McFall GP; Dixon RA
J Int Neuropsychol Soc; 2014 May; 20(5):478-86. PubMed ID: 24867440
[TBL] [Abstract][Full Text] [Related]
28. Age-Related Effects of the Apolipoprotein E Gene on Brain Function.
Matura S; Prvulovic D; Hartmann D; Scheibe M; Sepanski B; Butz M; Oertel-Knöchel V; Knöchel C; Karakaya T; Fußer F; Hattingen E; Pantel J
J Alzheimers Dis; 2016 Mar; 52(1):317-31. PubMed ID: 27003211
[TBL] [Abstract][Full Text] [Related]
29. Cerebrovascular disease, APOE epsilon4 allele and cognitive decline in a cognitively normal population.
Qiu C; Winblad B; Fratiglioni L
Neurol Res; 2006 Sep; 28(6):650-6. PubMed ID: 16945218
[TBL] [Abstract][Full Text] [Related]
30. Apolipoprotein E epsilon4 allele and lorazepam effects on memory in high-functioning older adults.
Pomara N; Willoughby L; Wesnes K; Greenblatt DJ; Sidtis JJ
Arch Gen Psychiatry; 2005 Feb; 62(2):209-16. PubMed ID: 15699298
[TBL] [Abstract][Full Text] [Related]
31. The contribution of apolipoprotein E alleles on cognitive performance and dynamic neural activity over six decades.
Alexander DM; Williams LM; Gatt JM; Dobson-Stone C; Kuan SA; Todd EG; Schofield PR; Cooper NJ; Gordon E
Biol Psychol; 2007 Jul; 75(3):229-38. PubMed ID: 17433528
[TBL] [Abstract][Full Text] [Related]
32. Establishing the limits and characteristics of normal age-related cognitive decline.
Ritchie K; Touchon J; Ledésert B; Leibovici D; Gorce AM
Rev Epidemiol Sante Publique; 1997 Oct; 45(5):373-81. PubMed ID: 9407625
[TBL] [Abstract][Full Text] [Related]
33. Interactions of functional apolipoprotein E gene promoter polymorphisms with smoking on aortic atherosclerosis.
Viiri LE; Viiri KM; Ilveskoski E; Huhtala H; Mäki M; Tienari PJ; Perola M; Lehtimäki T; Karhunen PJ
Circ Cardiovasc Genet; 2008 Dec; 1(2):107-16. PubMed ID: 20031552
[TBL] [Abstract][Full Text] [Related]
34. Effects of the APOE ε2 allele on mortality and cognitive function in the oldest old.
Lindahl-Jacobsen R; Tan Q; Mengel-From J; Christensen K; Nebel A; Christiansen L
J Gerontol A Biol Sci Med Sci; 2013 Apr; 68(4):389-94. PubMed ID: 23051975
[TBL] [Abstract][Full Text] [Related]
35. Apolipoprotein E and cognitive performance: a meta-analysis.
Small BJ; Rosnick CB; Fratiglioni L; Bäckman L
Psychol Aging; 2004 Dec; 19(4):592-600. PubMed ID: 15584785
[TBL] [Abstract][Full Text] [Related]
36. Association between white matter hyperintensity severity and cognitive impairment according to the presence of the apolipoprotein E (APOE) ε4 allele in the elderly: retrospective analysis of data from the CREDOS study.
Son SJ; Lee KS; Lee Y; Baek JH; Choi SH; Na DL; Seo SW; Oh BH; Hong CH
J Clin Psychiatry; 2012 Dec; 73(12):1555-62. PubMed ID: 23146133
[TBL] [Abstract][Full Text] [Related]
37. Risk-reducing Apolipoprotein E and Clusterin genotypes protect against the consequences of poor vascular health on executive function performance and change in nondemented older adults.
McFall GP; Sapkota S; McDermott KL; Dixon RA
Neurobiol Aging; 2016 Jun; 42():91-100. PubMed ID: 27143425
[TBL] [Abstract][Full Text] [Related]
38. Cognitive domain decline in healthy apolipoprotein E epsilon4 homozygotes before the diagnosis of mild cognitive impairment.
Caselli RJ; Reiman EM; Locke DE; Hutton ML; Hentz JG; Hoffman-Snyder C; Woodruff BK; Alexander GE; Osborne D
Arch Neurol; 2007 Sep; 64(9):1306-11. PubMed ID: 17846270
[TBL] [Abstract][Full Text] [Related]
39. The Effect of the APOE Genotype on Individual BrainAGE in Normal Aging, Mild Cognitive Impairment, and Alzheimer's Disease.
Löwe LC; Gaser C; Franke K;
PLoS One; 2016; 11(7):e0157514. PubMed ID: 27410431
[TBL] [Abstract][Full Text] [Related]
40. Association of Alzheimer's related genotypes with cognitive decline in multiple domains: results from the Three-City Dijon study.
Vivot A; Glymour MM; Tzourio C; Amouyel P; Chêne G; Dufouil C
Mol Psychiatry; 2015 Oct; 20(10):1173-8. PubMed ID: 26033242
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
